Enzyme vs Succinct — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Succinct trades at Rp2,647 (market cap Rp519,22M, Rp100,71M 24h volume). The key difference: Succinct is far larger — about 3.9× Enzyme's market cap, and Succinct's supply is capped (195M / 1B PROVE (20%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 29 Days and Succinct for 25 Days on average.
| MLN | PROVE | |
|---|---|---|
Market Cap | Rp134,13M | Rp519,22M |
Volume (24h) | Rp104,56M | Rp100,71M |
Circulating Supply | 3,3M MLN | 195M / 1B PROVE (20%) |
Typical Hold Time | 29 Days | 25 Days |
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
PROVE is trading at Rp2,672, showing a bearish technical trend with moving averages signaling strong selling pressure, though oscillators are neutral. The asset has a market cap of Rp518.94 million with 20% of its 1 million max supply in circulation. Current price sits between support at Rp2,576 and resistance at Rp2,729, with no major protocol updates or ecosystem news reported recently.
Overall outlook is cautious due to bearish technicals and low liquidity. Key opportunities include potential rebounds from oversold RSI levels, but risks are high from limited market depth, low circulating supply volatility, and absence of recent development activity. Investors should monitor for any new exchange listings or protocol announcements.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →Succinct is a protocol designed for verifiable computation, allowing developers to easily create and verify zero-knowledge (ZK) proofs in various contexts using its general-purpose zero-knowledge virtual machine (zkVM). Its mission is to establish cryptographic verifiability as a standard feature in blockchain, Web3 infrastructure, and beyond. This initiative aims to enhance the scalability, security, and trust-minimization of systems.
Read more on PROVE →